MedTrace Logo

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

NCT03453645 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-07-11

No results posted yet for this study

Summary

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias.

Conditions

  • Ventricular Tachycardia

Interventions

PROCEDURE

ventricular tachycardia ablation

The usual organization of hospitalization of the patients addressed for ventricular tachycardia ablation and his follow-up are not modified by the protocol. .

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Philippe MAURY, MD · University Hospital of Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-09
Primary Completion
2018-09-30
Completion
2019-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03453645 on ClinicalTrials.gov